Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension (Q37996827)

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Risk factors for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Imaging of the heart in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Medical management of primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNAs play an essential role in the development of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nocturnal hypoxemia is common in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Effects of inhaled salbutamol in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary function in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Exercise pathophysiology in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Guidelines for the diagnosis and treatment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The role of echocardiography in hemodynamic assessment in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic impact of right ventricular involvement as assessed by tricuspid annular motion in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Tricuspid annular displacement predicts survival in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of right ventricular function by strain rate imaging in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Quantitative three dimensional echocardiography in patients with pulmonary hypertension and compressed left ventricles: comparison with cross sectional echocardiography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Right ventricular function assessed by two-dimensional strain and tissue Doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension findings detected by F-18 FDG PET scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Low-dose ECG-gated 64-slices helical CT angiography of the chest: evaluation of image quality in 105 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Material differentiation by dual energy CT: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of pulmonary hypertension by CT and MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

End points and clinical trial design in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Early diagnosis of cor pulmonale with MR imaging of the right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Assessment of right ventricular diastolic and systolic function in patients with dilated cardiomyopathy using cine magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

NT-proBNP reflects right ventricular structure and function in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nitric oxide and cyclic GMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Urinary cGMP concentrations in severe primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Significance of a plasma D-dimer test in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevation of ELISA d-dimer levels in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Sitaxsentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

An integrated approach for experimental target identification of hypoxia-induced miR-210

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Superoxide in the pulmonary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Biological serum markers in the management of pediatric pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

IPF2alpha-I: an index of lipid peroxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Isoprostanes and lung vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased plasma serotonin in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Nitric oxide as a cellular antioxidant: a little goes a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxygen-dependent and -independent regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Signal transduction to hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Endothelin-1 in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-0950-4

Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

21 January 2018

1 reference

12 December 2020

Osteopontin in Patients With Idiopathic Pulmonary Hypertension

1 reference

12 December 2020

Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased

1 reference

12 December 2020

Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion

1 reference

12 December 2020

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension

1 reference

12 December 2020

Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension

1 reference

12 December 2020

Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation

1 reference

12 December 2020

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

12 December 2020

Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension

1 reference

12 December 2020

Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha

1 reference

12 December 2020

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

1 reference

12 December 2020

The roles of bcl-2 gene family in the pulmonary artery remodeling of hypoxia pulmonary hypertension in rats.

1 reference

12 December 2020

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

PPARgamma and the pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Assessment of pulmonary hypertension what CT and MRI can provide

1 reference

12 December 2020

Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation

1 reference

12 December 2020

Hyperuricemia in severe pulmonary hypertension

1 reference

12 December 2020

Role for miR-204 in human pulmonary arterial hypertension

1 reference

12 December 2020

Antinuclear antibodies in primary pulmonary hypertension

1 reference

12 December 2020

Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension

1 reference

12 December 2020

Cellular antioxidant and pro-oxidant actions of nitric oxide

1 reference

12 December 2020

End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives

1 reference

12 December 2020

Strain and strain rate echocardiography for evaluation of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Analysis of circulating microRNA: preanalytical and analytical challenges.

1 reference

12 December 2020

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Perspective on the optimal endpoints for pulmonary arterial hypertension trials

1 reference

12 December 2020

Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis

1 reference

12 December 2020

Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension

1 reference

12 December 2020

MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration

1 reference

12 December 2020

Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure

1 reference

12 December 2020

Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung

1 reference

12 December 2020

Endothelin-1/Endothelin-3 Ratio

1 reference

12 December 2020

Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy

1 reference

12 December 2020

Prognostic and predictive potential molecular biomarkers in colon cancer

1 reference

12 December 2020

Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy

1 reference

12 December 2020

Contemporary issues in pulmonary hypertension

1 reference

12 December 2020

Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma

1 reference

12 December 2020

Identification and Relative Quantitation of F2-Isoprostane Regioisomers Formed in vivo in the Rat

1 reference

12 December 2020

Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group

1 reference

12 December 2020

Reduction of claustrophobia during magnetic resonance imaging: methods and design of the "CLAUSTRO" randomized controlled trial

1 reference

12 December 2020

Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.

1 reference

12 December 2020

Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+

1 reference

12 December 2020

Increased sympathetic nerve activity in pulmonary artery hypertension

1 reference

12 December 2020

Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment

1 reference

12 December 2020

Antioxidant and oxidative stress changes in experimental cor pulmonale

1 reference

12 December 2020

Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease

1 reference

12 December 2020

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

12 December 2020

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging

1 reference

12 December 2020

1 reference

12 December 2020

Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination

1 reference

12 December 2020

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

1 reference

12 December 2020

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells

1 reference

12 December 2020

Assessment of cross-sectional lung ventilation-perfusion imbalance in primary and passive pulmonary hypertension with automated V/Q SPECT

1 reference

12 December 2020

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

1 reference

12 December 2020

The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography

1 reference

12 December 2020

Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

1 reference

12 December 2020

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

12 December 2020

Pulmonary hypertension

1 reference

12 December 2020

Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia

1 reference

12 December 2020

Therapie der pulmonal arteriellen Hypertonie (PAH)

1 reference

12 December 2020

Circulating biomarkers of tissue remodelling in pulmonary hypertension

1 reference

12 December 2020

Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques?

1 reference

12 December 2020

Serum concentration of cardiac troponin T in patients with cardiomyopathy: a possible mechanism of acute heart failure.

1 reference

12 December 2020

Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension

1 reference

12 December 2020

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

1 reference

12 December 2020

Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma

1 reference

12 December 2020

D-dimer and pulmonary arterial hypertension in systemic sclerosis

1 reference

12 December 2020

Early Stages of Mesothelioma, Screening and Biomarkers

1 reference

12 December 2020

Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension

1 reference

12 December 2020

A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension

1 reference

12 December 2020

Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia

1 reference

12 December 2020

Biochemical markers in the management of pulmonary hypertension.

1 reference

12 December 2020

Impaired stroke volume response to exercise in pulmonary arterial hypertension

1 reference

12 December 2020

CT Findings in Diseases Associated with Pulmonary Hypertension: A Current Review

1 reference

12 December 2020

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

1 reference

12 December 2020

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

1 reference

12 December 2020

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

1 reference

12 December 2020

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

1 reference

12 December 2020

Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation.

1 reference

12 December 2020

[Imaging of pulmonary arterial hypertension.]

1 reference

12 December 2020

Exercise testing to estimate survival in pulmonary hypertension

1 reference

12 December 2020

Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats

1 reference

12 December 2020

Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species

1 reference

12 December 2020

A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension

1 reference

12 December 2020

Left ventricular structure and function for postmyocardial infarction and heart failure risk stratification by three-dimensional echocardiography

1 reference

12 December 2020

MicroRNA-21 Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in Arteriosclerosis Obliterans of Lower Extremities

1 reference

12 December 2020

Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice

1 reference

12 December 2020

From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension

1 reference

12 December 2020

Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study

1 reference

12 December 2020

Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation

1 reference

12 December 2020

Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Endothelin-1 is elevated in monocrotaline pulmonary hypertension

1 reference

12 December 2020

Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension

1 reference

12 December 2020

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

1 reference

12 December 2020

Diagnosis and evaluation of pulmonary hypertension

1 reference

12 December 2020

Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension

1 reference

12 December 2020

Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension

1 reference

12 December 2020

Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension

1 reference

12 December 2020

Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension

1 reference

12 December 2020

Protein carbonylation as a novel mechanism in redox signaling

1 reference

12 December 2020

Clinical classification of pulmonary hypertension.

1 reference

12 December 2020

Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension

1 reference

12 December 2020

Superoxide as an intermediate signal for serotonin-induced mitogenesis

1 reference

12 December 2020

Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation

1 reference

12 December 2020

REVEAL Registry: Correlation of Right Heart Catheterization and Echocardiography in Patients With Pulmonary Arterial Hypertension

1 reference

12 December 2020

Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization.

1 reference

12 December 2020

Diagnostics in pulmonary hypertension.

1 reference

12 December 2020

The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension

1 reference

12 December 2020

Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

1 reference

12 December 2020